Progabide is an analog and prodrug of gamma-aminobutyric acid. It is commonly used in the treatment of epilepsy. It has agonistic activity for both the GABAA and GABAB receptors. Progabide has been investigated for many diseases besides epilepsy, including Parkinson's disease, schizophrenia, clinical depression and anxiety disorder with varying success.
Indication
Indicated for the treatment of epilepsy.
Pharmacology
Progabide, a fatty acid derivative, is a GABA receptor agonist used to treat the symptoms of epilepsy.
Affected Organisms
Humans and other mammals
Biotransformation
Hepatic
Absorption
Well absorbed with a bioavailability of 60%
Half Life
4 hours
Protein Binding
95%
References
•
Bartholini G, Scatton B, Zivkovic B, Lloyd KG: GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease. Adv Neurol. 1987;45:79-83.
[Pubmed]